All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Trade association.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $120,000.00 income · posted Apr 21, 2025

Official filing document

Bills named in this filing 2

HR 4370
SAMS Act of 2025
S 2220
Fighting for the Overlooked Recognition of Groups Operating in Toxic Test Environments in Nevada (FORGOTTEN) Veterans A…

Lobbying activity 3

Health Issues

Issues relating to drug pricing proposals including implementation of the Inflation Reduction Act (P.L. 117-169); Rx oversight issues; PBM oversight issues.

Trade (domestic/foreign)

Issues related to Section 301 tariffs; Issues related to IP protection; Market access issues.

Issues related to patent reform legislation; H.R. 4370/S. 2220 - The PREVAIL Act (118th Congress).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.